Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)

Autor: Mirna, Moritz, Lauten, Alexander, Jirak, Peter, Rezar, Richard, Wernly, Bernhard, Paar, Vera, Felder, Thomas K., Hoppe, Uta C., Motloch, Lukas J., Jung, Christian, Alushi, Brunilda, Lichtenauer, Michael, Salmhofer, Hermann
Zdroj: In European Journal of Internal Medicine March 2021 85:98-107
Databáze: ScienceDirect
Externí odkaz: